FDA panel recommends pulling Makena, citing ineffectiveness of controversial preterm birth dru - 1br

2022-10-20 3

The FDA advisory panel, made up of gynecologists, obstetricians and other fetal medicine experts, voted 14-1 to withdraw Makena from the market.

VIEW MORE : https://bit.ly/1breakingnews

Videos similaires

FDA yanks approval of Makena, only drug cleared to lower preterm birth - 1breakingnews.com

Mueller Recommends No Prison Time For Michael Flynn Citing 'Substantial' Cooperation

Study finds air pollution to be likely cause of up to 6m preterm births

CDC: Pregnant Women With COVID-19 At Higher Risk For Preterm Birth

Study finds air pollution to be likely cause of up to 6m preterm births

Study finds air pollution to be likely cause of up to 6m preterm births each year

Program claims to be reversing rates of preterm births

The long-term consequences of preterm birth revealed

Study finds air pollution to be likely cause of up to 6m preterm births

Preterm Birth Rates Improve in Most States

Web Analytics